PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers

Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):3973-3976. doi: 10.1007/s00259-022-05905-7.

Authors

Shuxian An¹, Gang Huang¹, Jianjun Liu¹, Weijun Wei²

Affiliations

¹ Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China.
² Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China. wwei@shsmu.edu.cn.

PMID: 35916921
DOI: 10.1007/s00259-022-05905-7

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antigens, Surface
Glutamate Carboxypeptidase II
Humans
Male
Precision Medicine*
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / therapy

Substances

Antigens, Surface
Glutamate Carboxypeptidase II